Home » PharmaVigilant Inks Contract With Synergy Pharmaceuticals
PharmaVigilant Inks Contract With Synergy Pharmaceuticals
PharmaVigilant, a clinical trial technology provider, has been selected by
Synergy Pharmaceuticals Inc. to support its one-year, multi-center Phase II study focused on the development of a new drug to treat gastrointestinal disorders
and diseases.
GEN
GEN
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May